When action movie star Chuck Norris earlier this month filed suit against firms involved in the distribution of gadolinium-based contrast agents, he put a human face on the gadolinium retention issue. MRI safety expert Dr. Emanuel Kanal of the University of Pittsburgh discusses the latest findings in what's known about gadolinium safety in this video.
Correction, Kanal Video 1 My MistakeVideo from RSNA 2017: Gadolinium retention debate takes center stage
Nov 28, 2017
Latest in Home
Medicare payment for cardiac CT declining
September 30, 2026
ASTRO: Shorter SBRT regimens improve patient physical function
September 30, 2026
ASTRO: Incoming president talks 2026 highlights, previews next year
September 30, 2026


















